Search details
1.
Flecainide Is Associated With a Lower Incidence of Arrhythmic Events in a Large Cohort of Patients With Catecholaminergic Polymorphic Ventricular Tachycardia.
Circulation
; 148(25): 2029-2037, 2023 12 19.
Article
in English
| MEDLINE | ID: mdl-37886885
2.
Long-term reliability of the phospholamban (PLN) p.(Arg14del) risk model in predicting major ventricular arrhythmia: a landmark study.
Europace
; 26(4)2024 Mar 30.
Article
in English
| MEDLINE | ID: mdl-38558121
3.
MYH7 p.(Arg1712Gln) is pathogenic founder variant causing hypertrophic cardiomyopathy with overall relatively delayed onset.
Neth Heart J
; 31(7-8): 300-307, 2023 Aug.
Article
in English
| MEDLINE | ID: mdl-37488328
4.
A randomized controlled trial of eplerenone in asymptomatic phospholamban p.Arg14del carriers.
Eur Heart J
; 44(40): 4284-4287, 2023 Oct 21.
Article
in English
| MEDLINE | ID: mdl-37210081
5.
ECG-only explainable deep learning algorithm predicts the risk for malignant ventricular arrhythmia in phospholamban cardiomyopathy.
Heart Rhythm
; 2024 Feb 23.
Article
in English
| MEDLINE | ID: mdl-38403235
6.
Arrhythmogenic right ventricular dysplasia/cardiomyopathy: pathogenic desmosome mutations in index-patients predict outcome of family screening: Dutch arrhythmogenic right ventricular dysplasia/cardiomyopathy genotype-phenotype follow-up study.
Circulation
; 123(23): 2690-700, 2011 Jun 14.
Article
in English
| MEDLINE | ID: mdl-21606396
7.
Clinical and genetic characterization of patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy caused by a plakophilin-2 splice mutation.
Cardiology
; 123(3): 181-9, 2012.
Article
in English
| MEDLINE | ID: mdl-23147395
8.
Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: proposed modification of the task force criteria.
Circulation
; 121(13): 1533-41, 2010 Apr 06.
Article
in English
| MEDLINE | ID: mdl-20172911
9.
Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: proposed modification of the Task Force Criteria.
Eur Heart J
; 31(7): 806-14, 2010 Apr.
Article
in English
| MEDLINE | ID: mdl-20172912
10.
Cardiac cell-cell junctions in health and disease: Electrical versus mechanical coupling.
J Mol Cell Cardiol
; 47(1): 23-31, 2009 Jul.
Article
in English
| MEDLINE | ID: mdl-19344726
11.
Activation delay and VT parameters in arrhythmogenic right ventricular dysplasia/cardiomyopathy: toward improvement of diagnostic ECG criteria.
J Cardiovasc Electrophysiol
; 19(8): 775-81, 2008 Aug.
Article
in English
| MEDLINE | ID: mdl-18373594
12.
Benefit of Implantable Cardioverter-Defibrillators in Patients With Catecholaminergic Polymorphic Ventricular Tachycardia.
JAMA Cardiol
; 7(11): 1175, 2022 11 01.
Article
in English
| MEDLINE | ID: mdl-36197658
13.
The challenge of early diagnosis in arrhythmogenic right ventricular dysplasia/cardiomyopathy.
J Cardiovasc Electrophysiol
; 19(11): 1135-6, 2008 Nov.
Article
in English
| MEDLINE | ID: mdl-18662177
14.
Left-dominant arrhythmogenic cardiomyopathy in a large family: associated desmosomal or nondesmosomal genotype?
Heart Rhythm
; 10(4): 548-59, 2013 Apr.
Article
in English
| MEDLINE | ID: mdl-23270881
15.
Arrhythmogenic right ventricular dysplasia/cardiomyopathy according to revised 2010 task force criteria with inclusion of non-desmosomal phospholamban mutation carriers.
Am J Cardiol
; 112(8): 1197-206, 2013 Oct 15.
Article
in English
| MEDLINE | ID: mdl-23871674
16.
Remodeling of the cardiac sodium channel, connexin43, and plakoglobin at the intercalated disk in patients with arrhythmogenic cardiomyopathy.
Heart Rhythm
; 10(3): 412-9, 2013 Mar.
Article
in English
| MEDLINE | ID: mdl-23178689
17.
Impact of new electrocardiographic criteria in arrhythmogenic cardiomyopathy.
Front Physiol
; 3: 352, 2012.
Article
in English
| MEDLINE | ID: mdl-23015790
18.
Impact of revised Task Force Criteria: distinguishing the athlete's heart from ARVC/D using cardiac magnetic resonance imaging.
Eur J Prev Cardiol
; 19(4): 885-91, 2012 Aug.
Article
in English
| MEDLINE | ID: mdl-21690305
19.
Early detection of regional functional abnormalities in asymptomatic ARVD/C gene carriers.
J Am Soc Echocardiogr
; 25(9): 997-1006, 2012 Sep.
Article
in English
| MEDLINE | ID: mdl-22727198
20.
Phospholamban R14del mutation in patients diagnosed with dilated cardiomyopathy or arrhythmogenic right ventricular cardiomyopathy: evidence supporting the concept of arrhythmogenic cardiomyopathy.
Eur J Heart Fail
; 14(11): 1199-207, 2012 Nov.
Article
in English
| MEDLINE | ID: mdl-22820313